Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
465.71
-4.51 (-0.96%)
Apr 29, 2026, 1:53 PM EDT - Market open
Thermo Fisher Revenue
Thermo Fisher had revenue of $11.01B in the quarter ending March 28, 2026, with 6.18% growth. This brings the company's revenue in the last twelve months to $45.20B, up 5.36% year-over-year. In the year 2025, Thermo Fisher had annual revenue of $44.56B with 3.91% growth.
Revenue (ttm)
$45.20B
Revenue Growth
+5.36%
P/S Ratio
3.83
Revenue / Employee
$361,576
Employees
125,000
Market Cap
173.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.56B | 1.68B | 3.91% |
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Danaher | 24.78B |
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.28B |
| Agilent Technologies | 7.07B |
| Illumina | 4.34B |
| IDEXX Laboratories | 4.30B |
| Mettler-Toledo International | 4.03B |
TMO News
- 1 day ago - Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of Life-changing Therapies - Business Wire
- 1 day ago - Thermo Fisher Scientific to Host Investor Day - Business Wire
- 2 days ago - Thermo Fisher to Sell Microbiology Business to Astorg - WSJ
- 2 days ago - Thermo Fisher to sell its microbiology business to Astorg for about $1.08 billion - Reuters
- 2 days ago - Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg - Business Wire
- 5 days ago - Thermo Fisher Flags 'Modest Inflation' Risk Amid Middle East Tensions - Benzinga
- 6 days ago - Thermo Fisher Scientific Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Thermo Fisher posts quarterly results beat as lab products, biopharma services grow - Reuters